Skip to main content
Division of Cardiovascular Medicine Division of Cardiovascular Medicine

General Cardiology Clinical Trials

Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health

Start Date: October 2025
Completion Date: January 2029 (estimated)
Recruitment Status: recruiting
Keywords: Metabolic Syndrome, Pre-diabetes, Time Restricted Eating, Fasting, Glucose Intolerance, Intermittent Fasting, Trehalase, Standard of Care, Time-restricted eating (TRE)

 

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Start Date: April 2025
Completion Date: December 2026 (estimated)
Recruitment Status: recruiting
Keywords: Drug Interactions, Primary Prevention, Cardiometabolic Syndrome, LDL-Cholersterol Lowering, Statin intolerance, drug drug interaction, inclisiran, LDL-Cholesterol, polypharmacy, multiple comorbidities, Metabolic Syndrome, ALN-PCS, Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

 

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Start Date: March 2024
Completion Date: March 2029 (estimated)
Recruitment Status: not accepting new patients
Keywords: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), ASCVD, LY3819469, lepodisiran, Atherosclerosis, Lepodisiran Sodium

 

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Start Date: March 2024
Completion Date: March 2030 (estimated)
Recruitment Status: recruiting
Keywords: Aortic Stenosis, Cardiovascular, Lipoprotein(a), Lp(a), Hyperlipoproteinemia(a), Calcific aortic valve stenosis, TQJ230, Pelacarsen, Aortic valve stenosis, Pelacarsen (TQJ230) 80mg

 

Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.

Start Date: July 2022
Completion Date: June 2025 (estimated)
Recruitment Status: not accepting new patients
Keywords: Postural Tachycardia Syndrome, Time-Restricted Eating, Intermittent fasting, POTS, Postural Orthostatic Tachycardia Syndrome, Tachycardia, Immune System Diseases, Time restricted eating

 

Time-Restricted Eating for Type II Diabetes: TRE-T2D

Start Date: May 2022
Completion Date: March 2026 (estimated)
Recruitment Status: accepting new patients
Keywords: Diabetes Mellitus, Type 2, Time Restricted Feeding, Diabetes type2, Diabetes Mellitus, Type 2 Diabetes Mellitus, Time-Restricted Eating

 

Impact of Time Restricted Eating on Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation

Start Date: September 2021
Completion Date: January 2025 (estimated)
Recruitment Status: not accepting new patients
Keywords: Coronary Artery Disease, Time Restricted Eating, Circadian Rhythm, Cardiac Rehabilitation, Intermittent Fasting, ICR (Intensive Cardiac Rehabilitation), ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating)

 

Registry of the Natural History of Recurrent Pericarditis in Pediatric and Adult Patients

Start Date: March 2021
Completion Date: March 2029 (estimated)
Recruitment Status: not accepting new patients
Keywords: Recurrent Pericarditis, Pericarditis, Inactive RP

 

Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults

Start Date: December 2020
Completion Date: January 2026 (estimated)
Recruitment Status: not accepting new patients
Keywords: Obesity, Key words provided by Michael Wilkinson, MD, University of California San Diego:, Catecholamine Sensitivity, Circadian Rhythm, Fasting, Time Restricted Eating, Weight Loss, Hypersensitivity

 

Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery

Start Date: May 2019
Completion Date: January 2028 (estimated)
Recruitment Status: accepting new patients
Keywords: CAD, Coronary, Computed Tomography, Coronary Artery Bypass, Atherosclerosis, Coronary Artery Disease, Myocardial Ischemia

 

Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Pulmonary Artery Denervation in Patients With Pulmonary Hypertension Due to Left Heart Disease

Start Date: November 2018
Completion Date: July 2027 (estimated)
Recruitment Status: in progress, not accepting new patients
Keywords: Pulmonary Hypertension (PH) Due to Left Heart Disease, Pulmonary Hypertension, Hypertension, Heart Diseases, Pulmonary Denervation

 

Find more clinical trials at https://clinicaltrials.ucsd.edu